SCHEMBL21152476

SCHEMBL21152476

C=C1NCc2cc(Br)sc21

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PNMT P11086 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15763745 0.66 PNMT (0.35) PNMT
SCHEMBL18612880 0.66 PNMT (0.35) PNMT
SCHEMBL12711531 0.60 PNMT (0.32) PNMT
SCHEMBL23177730 0.59 CDK1 (0.39)
SCHEMBL23462404 0.56 MAOA (0.35)
SCHEMBL12665934 0.56 PNMT (0.47) PNMT
SCHEMBL19704634 0.55 SNCA (0.42)
SCHEMBL23142306 0.54 PNMT (0.45) PNMT
SCHEMBL23142209 0.54 PNMT (0.49) PNMT
SCHEMBL19621755 0.54

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020046975-A1 METHODS OF TREATING NEURODEGENERATIVE DISEASES Seal Rock Therapeutics, Inc. (US) 2020-03-05 WO disclosed
WO-2019136025-A1 ASK1 INHIBITOR COMPOUNDS AND USES THEREOF Seal Rock Therapeutics, Inc. (US) 2019-07-11 WO disclosed